20/03/2026
Following SOPs is fundamental in sterile pharmaceutical operations—no compromise there.
But here’s a perspective we don’t discuss enough:
👉 Strict adherence to SOPs is good but critically evaluating their deficiencies is equally important.
In pharma microbiology, many recurring issues and even regulatory observations do not happen solely because people ignore SOPs, they happen because:
🔍 SOPs are not scientifically robust
They may lack clarity on critical steps like disinfection contact time, sampling techniques, sampling locations, intervention handling etc.
📄 Procedures don’t reflect real operations
What is written may not align with what actually happens on the floor - creating gaps during ex*****on.
⚠️ Edge cases are not addressed
Deviations, atypical conditions, or worst-case scenarios are often missing or vaguely defined.
🔄 Periodic reviews become routine
SOPs are “reviewed” but not truly challenged or improved based on trends, deviations, or new regulatory expectations.
🧪 Microbiological risks are underestimated
Procedures may focus on compliance, but not fully consider contamination risks in dynamic environments - Missing Risk-based approach
🤝 Lack of inclusive discussion during SOP design
When SOPs are created in isolation, they miss practical insights. An inclusive environment - where operators, microbiologists, QA, and engineering teams openly share their thought processes - helps build a watertight procedures that are realistic, risk-based, and effective.
💡 The strongest systems are built when:
• Every employee feels empowered to question and improve processes
• Shopfloor experiences are valued as much as documented knowledge
• Cross-functional inputs shape robust and practical SOPs
In reality, an outdated or weak SOP - no matter how well followed can still lead to failure:
✅ A strong quality culture doesn’t just ask: “Are we following the SOP?”
✅ It also asks: “Is this SOP still the right one and was it built with the right inputs?”
Because in sterile pharma, compliance without scientific scrutiny and without inclusive thinking is a hidden risk—one that will eventually lead to failure, whether in the short term or the long term.
👉 How much do you agree with this perspective?
👉 Let me know your thoughts and challenges—have you faced similar situations?
📩 Connect with Consult MicroBio for consulting and product offerings.
At Consult MicroBio, we are on a mission to make scientific tools affordable and accessible for the pharma microbiology community.
📧 [email protected]
🌐 www.consultmicrobio.com
